Literature DB >> 23728790

mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.

Shireena A Yasin1, Abu M Ali, Mathew Tata, Simon R Picker, Glenn W Anderson, Elizabeth Latimer-Bowman, Sarah L Nicholson, William Harkness, J Helen Cross, Simon M L Paine, Thomas S Jacques.   

Abstract

Focal cortical dysplasia (FCD) is a localized malformation of cortical development and is the commonest cause of severe childhood epilepsy in surgical practice. Children with FCD are severely disabled by their epilepsy, presenting with frequent seizures early in life. The commonest form of FCD in children is characterized by the presence of an abnormal population of cells, known as balloon cells. Similar pathological changes are seen in the cortical malformations that characterize patients with tuberous sclerosis complex (TSC). However, the cellular and molecular mechanisms that underlie the malformations of FCD and TSC are not well understood. We provide evidence for a defect in autophagy in FCD and TSC. We have found that balloon cells contain vacuoles that include components of the autophagy pathway. Specifically, we show that balloon cells contain prominent lysosomes by electron microscopy, immunohistochemistry for LAMP1 and LAMP2, LysoTracker labelling and enzyme histochemistry for acid phosphatase. Furthermore, we found that balloon cells contain components of the ATG pathway and that there is cytoplasmic accumulation of the regulator of autophagy, DOR. Most importantly we found that there is abnormal accumulation of the autophagy cargo protein, p62. We show that this defect in autophagy can be, in part, reversed in vitro by inhibition of the mammalian target of rapamycin (mTOR) suggesting that abnormal activation of mTOR may contribute directly to a defect in autophagy in FCD and TSC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23728790     DOI: 10.1007/s00401-013-1135-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

Review 1.  mTOR signaling in epilepsy: insights from malformations of cortical development.

Authors:  Peter B Crino
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

Review 2.  mTOR inhibition in epilepsy: rationale and clinical perspectives.

Authors:  Adam P Ostendorf; Michael Wong
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

Review 3.  The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations.

Authors:  Filippo Sean Giorgi; Francesca Biagioni; Paola Lenzi; Alessandro Frati; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

Review 4.  Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism.

Authors:  Darius Ebrahimi-Fakhari; Afshin Saffari; Lara Wahlster; Jenny Lu; Susan Byrne; Georg F Hoffmann; Heinz Jungbluth; Mustafa Sahin
Journal:  Brain       Date:  2015-12-29       Impact factor: 13.501

Review 5.  Epilepsy related to developmental tumors and malformations of cortical development.

Authors:  Eleonora Aronica; Peter B Crino
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 6.  Hemispheric malformations of cortical development: surgical indications and approach.

Authors:  Bradley Lega; Jeffrey Mullin; Elaine Wyllie; William Bingaman
Journal:  Childs Nerv Syst       Date:  2014-10-09       Impact factor: 1.475

7.  Impaired Mitochondrial Dynamics and Mitophagy in Neuronal Models of Tuberous Sclerosis Complex.

Authors:  Darius Ebrahimi-Fakhari; Afshin Saffari; Lara Wahlster; Alessia Di Nardo; Daria Turner; Tommy L Lewis; Christopher Conrad; Jonathan M Rothberg; Jonathan O Lipton; Stefan Kölker; Georg F Hoffmann; Min-Joon Han; Franck Polleux; Mustafa Sahin
Journal:  Cell Rep       Date:  2016-10-18       Impact factor: 9.423

Review 8.  Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.

Authors:  Kim M Keppler-Noreuil; Victoria E R Parker; Thomas N Darling; Julian A Martinez-Agosto
Journal:  Am J Med Genet C Semin Med Genet       Date:  2016-11-18       Impact factor: 3.908

9.  Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.

Authors:  Jae Seok Lim; Woo-il Kim; Hoon-Chul Kang; Se Hoon Kim; Ah Hyung Park; Eun Kyung Park; Young-Wook Cho; Sangwoo Kim; Ho Min Kim; Jeong A Kim; Junho Kim; Hwanseok Rhee; Seok-Gu Kang; Heung Dong Kim; Daesoo Kim; Dong-Seok Kim; Jeong Ho Lee
Journal:  Nat Med       Date:  2015-03-23       Impact factor: 53.440

Review 10.  Adoptive Autophagy Activation: a Much-Needed Remedy Against Chemical Induced Neurotoxicity/Developmental Neurotoxicity.

Authors:  A Srivastava; V Kumar; A Pandey; S Jahan; D Kumar; C S Rajpurohit; S Singh; V K Khanna; A B Pant
Journal:  Mol Neurobiol       Date:  2016-02-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.